The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3

Biological Chemistry

Volumn 394, Issue 4, 2013, Pages 449-457

  Jaakkola, Panu M ^a,b   Rantanen, Krista ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aggresome; Egg laying deficiency protein ninelike protein or prolyl 4 hydroxylase domain protein 3 (EGLN); Hypoxia; Hypoxia inducible factor (HIF); Oxygen sensor; P62; Von Hippel Lindau protein (pVHL)

Indexed keywords

HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 2ALPHA; I KAPPA B KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL 4 HYDROXYLASE DOMAIN PROTEIN 3; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

APOPTOSIS; AUTOPHAGY; BREAST CARCINOMA; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HYPOXIA; IN VIVO STUDY; KIDNEY CELL; METABOLIC STRESS; MICROENVIRONMENT; NEOPLASM; NONHUMAN; OXYGEN SENSING; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STRESS FIBER; TUMOR DIFFERENTIATION; UBIQUITINATION; UPREGULATION;

ANIMALS; ANOXIA; DIOXYGENASES; HUMANS; ISCHEMIA; OXYGEN; PROCOLLAGEN-PROLINE DIOXYGENASE;

EID: 84882267740     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0330     Document Type: Review

References (69)

1. Appelhoff, R.J., Tian, Y.M., Raval, R.R., Turley, H., Harris, A.L., Pugh, C.W., Ratcliffe, P.J., and Gleadle, J.M. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465.
2. Aprelikova, O., Chandramouli, G.V., Wood, M., Vasselli, J.R., Riss, J., Maranchie, J.K., Linehan, W.M., and Barrett, J.C. (2004). Regulation of HIF prolyl hydroxylases by hypoxiainducible factors. J. Cell. Biochem. 92, 491-501.
3. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D., and Pouyssegur, J. (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22, 4082-4090.
4. Bishop, T., Gallagher, D., Pascual, A., Lygate, C.A., de Bono, J.P., Nicholls, L.G., Ortega-Saenz, P., Oster, H., Wijeyekoon, B., Sutherland, A.I., et al. (2008). Abnormal sympathoadrenal development and systemic hypotension in PHD3 -/- mice. Mol. Cell. Biol. 28, 3386-3400.
5. Bruick, R.K. and McKnight, S.L. (2001). A conserved family of prolyl- 4-hydroxylases that modify HIF. Science 294, 1337-1340.
6. Cervera, A.M., Apostolova, N., Luna-Crespo, F., Sanjuan-Pla, A., Garcia-Bou, R., and McCreath, K.J. (2006). An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity. Cancer Lett. 233, 131-138.
7. Chen, N., Rinner, O., Czernik, D., Nytko, K.J., Zheng, D., Stiehl, D.P., Zamboni, N., Gstaiger, M., and Frei, C. (2011). The oxygen sensor PHD3 limits glycolysis under hypoxia via direct binding to pyruvate kinase. Cell Res. 21, 983-986.
8. Cockman, M.E., Masson, N., Mole, D.R., Jaakkola, P., Chang, G.W., Clifford, S.C., Maher, E.R., Pugh, C.W., Ratcliffe, P.J., and Maxwell, P.H. (2000). Hypoxia inducible factor-κBinding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733-25741.
9. Cummins, E.P., Berra, E., Comerford, K.M., Ginouves, A., Fitzgerald, K.T., Seeballuck, F., Godson, C., Nielsen, J.E., Moynagh, P., Pouyssegur, J., et al. (2006). Prolyl hydroxylase-1 negatively regulates I κB kinase- β, giving insight into hypoxiainduced NF-κB activity. Proc. Natl. Acad. Sci. USA 103, 18154-18159.
10. del Peso, L., Castellanos, M.C., Temes, E., Martin-Puig, S., Cuevas, Y., Olmos, G., and Landazuri, M.O. (2003). The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278, 48690-48695.
11. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
12. Fu, J. and Taubman, M.B. (2010). Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-κB-dependent pathway. J. Biol. Chem. 285, 8927-8935.
13. Fu, J., Menzies, K., Freeman, R.S., and Taubman, M.B. (2007). EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability. J. Biol. Chem. 282, 12410-12418.
14. Ginouves, A., Ilc, K., Macias, N., Pouyssegur, J., and Berra, E. (2008). PHDs overactivation during chronic hypoxia'desensitizes'HIFα and protects cells from necrosis. Proc. Natl. Acad. Sci. USA 105, 4745-4750.
15. Gossage, L., Zaitoun, A., Fareed, K.R., Turley, H., Aloysius, M., Lobo, D.N., Harris, A.L., and Madhusudan, S. (2010). Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer. Histopathology 56, 908-920.
16. Hatzimichael, E., Dasoula, A., Shah, R., Syed, N., Papoudou-Bai, A., Coley, H.M., Dranitsaris, G., Bourantas, K.L., Stebbing, J., and Crook, T. (2010). The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia. Eur. J. Haematol. 84, 47-51.
17. Heikkinen, P.T., Nummela, M., Jokilehto, T., Grenman, R., Kahari, V.M., and Jaakkola, P.M. (2010). Hypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasion. Cancer Res. 70, 5984-5993.
18. Henze, A.T., Riedel, J., Diem, T., Wenner, J., Flamme, I., Pouyseggur, J., Plate, K.H., and Acker, T. (2010). Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxiainducible factors. Cancer Res. 70, 357-366.
19. Hirsila, M., Koivunen, P., Gunzler, V., Kivirikko, K.I., and Myllyharju, J. (2003). Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278, 30772-30780.
20. Hogel, H., Rantanen, K., Jokilehto, T., Grenman, R., and Jaakkola, P.M. (2011). Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells. PLoS One 6, e27112.
21. Isaacs, J.S., Jung, Y.J., Mole, D.R., Lee, S., Torres-Cabala, C., Chung, Y.L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143-153.
22. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J.M., Lane, W.S., and Kaelin, W.G., Jr. (2001). HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O 2 sensing. Science 292, 464-468.
23. Jaakkola, P.M. and Pursiheimo, J.P. (2009). p62 degradation by autophagy: another way for cancer cells to survive under hypoxia. Autophagy 5, 410-412.
24. Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., Kriegsheim Av, A., Hebestreit, H.F., Mukherji, M., Schofield, C.J., et al. (2001). Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O 2 -regulated prolyl hydroxylation. Science 292, 468-472.
25. Jokilehto, T. and Jaakkola, P.M. (2010). The role of HIF prolyl hydroxylases in tumour growth. J. Cell. Mol. Med. 14, 758-770.
26. Jokilehto, T., Rantanen, K., Luukkaa, M., Heikkinen, P., Grenman, R., Minn, H., Kronqvist, P., and Jaakkola, P.M. (2006). Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clin. Cancer Res. 12, 1080-1087.
27. Jokilehto, T., Hogel, H., Heikkinen, P., Rantanen, K., Elenius, K., Sundstrom, J., and Jaakkola, P.M. (2010). Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth. Exp. Cell Res. 316, 1169-1178.
28. Kaelin, W.G., Jr. and Ratcliffe, P.J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402.
29. Koditz, J., Nesper, J., Wottawa, M., Stiehl, D.P., Camenisch, G., Franke, C., Myllyharju, J., Wenger, R.H., and Katschinski, D.M. (2007). Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 15, 3610-3617.
30. Koivunen, P., Hirsila, M., Remes, A.M., Hassinen, I.E., Kivirikko, K.I., and Myllyharju, J. (2007a). Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282, 4524-4532.
31. Koivunen, P., Tiainen, P., Hyvärinen, J., Williams, K.E., Sormunen, R., Klaus, S.J., Kivirikko, K.I., and Myllyharju, J. (2007b). An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor α. J. Biol. Chem. 282, 30544-30552.
32. Koivunen, P., Lee, S., Duncan, C.G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J.A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012). Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483, 484-488.
33. Laitala, A., Aro, E., Walkinshaw, G., Maki, J.M., Rossi, M., Heikkila, M., Savolainen, E.R., Arend, M., Kivirikko, K.I., Koivunen, P., et al. (2012). Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis. Blood 120, 3336-3344.
34. Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M.S., Sajan, M.P., Farese, R.V., Freeman, R.S., Carter, B.D., Kaelin, W.G., Jr., et al. (2005). Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8, 155-167.
35. Lipscomb, E.A., Sarmiere, P.D., Crowder, R.J., and Freeman, R.S. (1999). Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. J. Neurochem. 73, 429-432.
36. Lipscomb, E.A., Sarmiere, P.D., and Freeman, R.S. (2001). SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 276, 5085-5092.
37. Liu, Y., Huo, Z., Yan, B., Lin, X., Zhou, Z.N., Liang, X., Zhu, W., Liang, D., Li, L., Zhao, H., et al. (2010). Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells. Biochem. Biophys. Res. Commun. 401, 231-237.
38. Lu, H., Dalgard, C.L., Mohyeldin, A., McFate, T., Tait, A.S., and Verma, A. (2005). Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280, 41928-41939.
39. Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R.N., Pandey, A., and Semenza, G.L. (2011). Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxiainducible factor 1. Cell 145, 732-744.
40. Luu, V.D., Boysen, G., Struckmann, K., Casagrande, S., von Teichman, A., Wild, P.J., Sulser, T., Schraml, P., and Moch, H. (2009). Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clin. Cancer Res. 15, 3297-3304.
41. Marxsen, J.H., Stengel, P., Doege, K., Heikkinen, P., Jokilehto, T., Wagner, T., Jelkmann, W., Jaakkola, P., and Metzen, E. (2004). Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-a-prolyl-4- hydroxylases. Biochem. J. 381, 761-767.
42. Masson, N., Willam, C., Maxwell, P.H., Pugh, C.W., and Ratcliffe, P.J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206.
43. Masson, N., Appelhoff, R.J., Tuckerman, J.R., Tian, Y.M., Demol, H., Puype, M., Vandekerckhove, J., Ratcliffe, P.J., and Pugh, C.W. (2004). The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. FEBS Lett. 570, 166-170.
44. Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J.H., Stolze, I., Klinger, M., Huang, W.Q., Wotzlaw, C., Hellwig- Burgel, T., Jelkmann, W., et al. (2003). Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326.
45. Moschella, M.C., Menzies, K., Tsao, L., Lieb, M.A., Kohtz, J.D., Kohtz, D.S., and Taubman, M.B. (1999). SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation. Gene Expr. 8, 59-66.
46. Muratovska, A., Zhou, C., He, S., Goodyer, P., and Eccles, M.R. (2003). Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22, 7989-7997.
47. Nakayama, K., Frew, I.J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P.B., et al. (2004). Siah2 regulates stability of prolylhydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952.
48. Nakayama, K., Gazdoiu, S., Abraham, R., Pan, Z.Q., and Ronai, Z. (2007). Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2. Biochem. J. 401, 217-226.
49. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V., and Kaelin, W.G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell. Biol. 2, 423-427.
50. Pescador, N., Cuevas, Y., Naranjo, S., Alcaide, M., Villar, D., Landazuri, M.O., and Del Peso, L. (2005). Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 390, 189-197.
51. Pientka, F.K., Hu, J., Schindler, S.G., Brix, B., Thiel, A., Joehren, O., Fandrey, J., Berchner-Pfannschmidt, U., and Depping, R. (2012). Oxygen sensing by prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartimentalisation on HIF-1 signalling. J. Cell Sci. 125, 5168-5176.
52. Place, T.L., Fitzgerald, M.P., Venkataraman, S., Vorrink, S.U., Case, A.J., Teoh, M.L., and Domann, F.E. (2011). Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells. PLoS One 6, e14617.
53. Pursiheimo, J.P., Rantanen, K., Heikkinen, P.T., Johansen, T., and Jaakkola, P.M. (2008). Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 28, 334-344.
54. Rantanen, K., Pursiheimo, J., Hogel, H., Himanen, V., Metzen, E., and Jaakkola, P.M. (2008). Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation. Mol. Biol. Cell 19, 2231-2240.
55. Rohrbach, S., Simm, A., Pregla, R., Franke, C., and Katschinski, D.M. (2005). Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart. Biogerontology 6, 165-171.
56. Sato, M., Sakota, M., and Nakayama, K. (2010). Human PRP19 interacts with prolyl-hydroxylase PHD3 and inhibits cell death in hypoxia. Exp. Cell. Res. 316, 2871-2882.
57. Schlisio, S. (2009). Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum. J. Cell. Mol. Med. 13, 4104-4112.
58. Schlisio, S., Kenchappa, R.S., Vredeveld, L.C., George, R.E., Stewart, R., Greulich, H., Shahriari, K., Nguyen, N.V., Pigny, P., Dahia, P.L., et al. (2008). The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes. Dev. 22, 884-893.
59. Schofield, C.J. and Ratcliffe, P.J. (2004). Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343-354.
60. Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B., and Gottlieb, E. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell. 7, 77-85.
61. Su, Y., Loos, M., Giese, N., Hines, O.J., Diebold, I., Gorlach, A., Metzen, E., Pastorekova, S., Friess, H., and Buchler, P. (2010). PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer. Br. J. Cancer 103, 1571-1579.
62. Tennant, D.A. and Gottlieb, E. (2010). HIF prolyl hydroxylase-3 mediates α-ketoglutarate-induced apoptosis and tumor suppression. J. Mol. Med. (Berl.) 88, 839-849.
63. Walmsley, S.R., Chilvers, E.R., Thompson, A.A., Vaughan, K., Marriott, H.M., Parker, L.C., Shaw, G., Parmar, S., Schneider, M., Sabroe, I., et al. (2011). Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J. Clin. Invest. 121, 1053-1063.
64. Wax, S.D., Rosenfield, C.L., and Taubman, M.B. (1994). Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J. Biol. Chem. 269, 13041-13047.
65. Wax, S.D., Tsao, L., Lieb, M.E., Fallon, J.T., and Taubman, M.B. (1996). SM-20 is a novel 40-kd protein whose expression in the arterial wall is restricted to smooth muscle. Lab. Invest. 74, 797-808.
66. Willam, C., Maxwell, P.H., Nichols, L., Lygate, C., Tian, Y.M., Bernhardt, W., Wiesener, M., Ratcliffe, P.J., Eckardt, K.U., and Pugh, C.W. (2006). HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation. J. Mol. Cell. Cardiol. 41, 68-77.
67. Xie, L., Xiao, K., Whalen, E.J., Forrester, M.T., Freeman, R.S., Fong, G., Gygi, S.P., Lefkowitz, R.J., and Stamler, J.S. (2009). Oxygen-regulated β2 -adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci. Signal. 2, ra33.
68. Xue, J., Li, X., Jiao, S., Wei, Y., Wu, G., and Fang, J. (2010). Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKβ independent of hydroxylase activity. Gastroenterology 138, 606-615.
69. Yan, B., Jiao, S., Zhang, H.S., Lv, D.D., Xue, J., Fan, L., Wu, G.H., and Fang, J. (2011). Prolyl hydroxylase domain protein 3 targets Pax2 for destruction. Biochem. Biophys. Res. Commun. 409, 315-320.